Rationale and design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (the POSEIDON-DCM study): a phase I/II, randomized pilot study of the comparative safety and efficacy of transendocardial inject (Q42554253)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 October 2014

Language	Label	Description	Also known as
English	Rationale and design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (the POSEIDON-DCM study): a phase I/II, randomized pilot study of the comparative safety and efficacy of transendocardial inject	scientific article published on 30 October 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Rationale and design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (the POSEIDON-DCM study): a phase I/II, randomized pilot study of the comparative safety and efficacy of transendocardial inject (English)

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

dilated cardiomyopathy

1 reference

based on heuristic

inferred from title

author name string

Muzammil Mushtaq

1

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Darcy L DiFede

2

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Samuel Golpanian

3

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Aisha Khan

4

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Samirah A Gomes

5

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Adam Mendizabal

6

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Alan W Heldman

7

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Joshua M Hare

8

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

language of work or name

0 references

publication date

30 October 2014

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Journal of Cardiovascular Translational Research

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

7

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

9

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

769-780

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

https://scigraph.springernature.com/pub.10.1007/s12265-014-9594-0

0 references

Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Impact of nonischemic scar features on local ventricular electrograms and scar-related ventricular tachycardia circuits in patients with nonischemic cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

A characterization and targeting of the infarct border zone in a swine model of myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Transcriptomic biomarkers for the accurate diagnosis of myocarditis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

The gene expression profile of patients with new-onset heart failure reveals important gender-specific differences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Transcriptomic biomarkers for individual risk assessment in new-onset heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Trends in prevalence and outcome of heart failure with preserved ejection fraction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

The Seattle Heart Failure Model: prediction of survival in heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

28 May 2018

Do we have a future with transcatheter adventitial delivery of stem cells?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

16 August 2018

One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

16 August 2018

Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

16 August 2018

A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

16 August 2018

Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

16 August 2018

Third Universal Definition of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9594-0

21 January 2018

Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9594-0

21 January 2018

Myocardial repair by percutaneous cell transplantation of autologous skeletal myoblast as a stand alone procedure in post myocardial infarction chronic heart failure patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4303027

3 November 2018

Pressure overload leads to an increase of cardiac resident stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9594-0

21 January 2018

Cell-based therapies for myocardial repair: emerging role for bone marrow-derived mesenchymal stem cells (MSCs) in the treatment of the chronically injured heart

1 reference

https://pubmed.ncbi.nlm.nih.gov/25354998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The variable natural history of idiopathic dilated cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25354998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25354998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A safety and feasibility study of cell therapy in dilated cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25354998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ischemic cardiomyopathy: endomyocardial biopsy and ventriculographic evaluation of patients with congestive heart failure, dilated cardiomyopathy and coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25354998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First experience with remote left ventricular mapping and transendocardial cell injection with a novel integrated magnetic navigation-guided electromechanical mapping system

1 reference

https://pubmed.ncbi.nlm.nih.gov/25354998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Embryonic Stem Cells and Released Factors Stimulate c-kit(+)/FLK-1(+) Progenitor Cells and Promote Neovascularization in Doxorubicin-Induced Cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25354998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12265-014-9594-0

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42554253&oldid=1575317402"